• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

SGLT2 inhibitors and mortality in diabetic cancer patients: cardioprotective and anticancer effects.

作者信息

Keramida Kalliopi, Ahmed Ali, Filippatos Gerasimos

机构信息

Department of Cardiology, General Anticancer Oncological Hospital, Agios Savvas, Athens 11522, Greece.

Department of Medicine, Veterans Affairs Medical Center, Washington, DC 20422, USA.

出版信息

Eur Heart J Cardiovasc Pharmacother. 2025 Aug 12;11(5):399-401. doi: 10.1093/ehjcvp/pvaf044.

DOI:10.1093/ehjcvp/pvaf044
PMID:40474670
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12343019/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ac/12343019/66ce13d2f134/pvaf044f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ac/12343019/66ce13d2f134/pvaf044f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53ac/12343019/66ce13d2f134/pvaf044f1.jpg

相似文献

1
SGLT2 inhibitors and mortality in diabetic cancer patients: cardioprotective and anticancer effects.钠-葡萄糖协同转运蛋白2抑制剂与糖尿病癌症患者的死亡率：心脏保护和抗癌作用
Eur Heart J Cardiovasc Pharmacother. 2025 Aug 12;11(5):399-401. doi: 10.1093/ehjcvp/pvaf044.
2
Effects of RAS and SGLT2 inhibitors alone or in combination on end-stage kidney disease and/or all-cause death in patients with both diabetes and hypertension: a nationwide cohort study.肾素-血管紧张素系统（RAS）抑制剂和钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂单用或联用对糖尿病合并高血压患者终末期肾病和/或全因死亡的影响：一项全国性队列研究
Cardiovasc Diabetol. 2025 Jul 14;24(1):288. doi: 10.1186/s12933-025-02846-x.
3
The impact of metformin on kidney disease progression and mortality in diabetic patients using SGLT2 inhibitors: a real-world cohort study.二甲双胍对使用钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂的糖尿病患者肾脏疾病进展和死亡率的影响：一项真实世界队列研究。
Cardiovasc Diabetol. 2025 Feb 28;24(1):97. doi: 10.1186/s12933-025-02643-6.
4
A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy.糖尿病肾病模型中 SGLT2 抑制剂对肾脏影响的系统评价
Pharmacol Ther. 2023 Sep;249:108503. doi: 10.1016/j.pharmthera.2023.108503. Epub 2023 Jul 24.
5
Exploring the Role of SGLT2 Inhibitors in Cancer: Mechanisms of Action and Therapeutic Opportunities.探索SGLT2抑制剂在癌症中的作用：作用机制与治疗机会
Cancers (Basel). 2025 Jan 30;17(3):466. doi: 10.3390/cancers17030466.
6
The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors: State-of-the-Art Review.钠-葡萄糖协同转运蛋白2抑制剂的心脏保护和抗癌作用：最新综述
JACC CardioOncol. 2024 Mar 12;6(2):159-182. doi: 10.1016/j.jaccao.2024.01.007. eCollection 2024 Apr.
7
The influence of sodium-glucose co-transporter-2 inhibitors on the risk of cancer therapy-related cardiac dysfunction: A meta-analysis.钠-葡萄糖协同转运蛋白2抑制剂对癌症治疗相关心脏功能障碍风险的影响：一项荟萃分析。
Biomol Biomed. 2025 Mar 10. doi: 10.17305/bb.2025.11847.
8
Comparative safety of sodium-glucose co-transporter 2 inhibitors in elderly patients with type 2 diabetes mellitus and diabetic kidney disease: a systematic review and meta-analysis.钠-葡萄糖共转运蛋白 2 抑制剂在老年 2 型糖尿病合并糖尿病肾病患者中的安全性比较：系统评价和荟萃分析。
Ren Fail. 2023 Dec;45(1):2217287. doi: 10.1080/0886022X.2023.2217287.
9
Cardiorenal Benefits of SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Concomitant Hypertension.钠-葡萄糖协同转运蛋白2抑制剂对慢性肾脏病合并高血压患者的心肾益处
Cardiorenal Med. 2025;15(1):496-509. doi: 10.1159/000545622. Epub 2025 Apr 21.
10
Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.2型糖尿病治疗效果的年龄和性别差异：一项网状Meta分析
JAMA. 2025 Mar 25;333(12):1062-1073. doi: 10.1001/jama.2024.27402.

本文引用的文献

1
Cancer-nervous system crosstalk: from biological mechanism to therapeutic opportunities.癌症-神经系统相互作用：从生物学机制到治疗机遇
Mol Cancer. 2025 May 5;24(1):133. doi: 10.1186/s12943-025-02336-4.
2
Effects of SGLT2 Inhibitors in Patients with Cancer and Diabetes Mellitus: A Systematic Review and Meta-analysis.SGLT2抑制剂对癌症合并糖尿病患者的影响：一项系统评价与Meta分析
Eur Heart J Cardiovasc Pharmacother. 2025 Apr 25. doi: 10.1093/ehjcvp/pvaf028.
3
Impact of sodium-glucose cotransporter-2 inhibitors on heart failure outcomes in cancer patients and survivors: a systematic review and meta-analysis.
钠-葡萄糖协同转运蛋白2抑制剂对癌症患者及幸存者心力衰竭结局的影响：一项系统评价和荟萃分析。
Eur J Prev Cardiol. 2025 Mar 6. doi: 10.1093/eurjpc/zwaf026.
4
Multifaceted Impact of SGLT2 Inhibitors in Heart Failure Patients: Exploring Diverse Mechanisms of Action.钠-葡萄糖协同转运蛋白2抑制剂对心力衰竭患者的多方面影响：探索多种作用机制
Biomedicines. 2024 Oct 11;12(10):2314. doi: 10.3390/biomedicines12102314.
5
The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors: State-of-the-Art Review.钠-葡萄糖协同转运蛋白2抑制剂的心脏保护和抗癌作用：最新综述
JACC CardioOncol. 2024 Mar 12;6(2):159-182. doi: 10.1016/j.jaccao.2024.01.007. eCollection 2024 Apr.
6
Cardiovascular outcomes associated with SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus and cancer: a systematic review and meta-analysis.2型糖尿病合并癌症患者中与钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂治疗相关的心血管结局：一项系统评价和荟萃分析
Diabetol Metab Syndr. 2024 May 22;16(1):108. doi: 10.1186/s13098-024-01354-4.
7
A comparative study on the effect of SGLT2 inhibitors on chemosensitivity to doxorubicin in MCF-7 breast cancer cells.SGLT2 抑制剂对 MCF-7 乳腺癌细胞多柔比星化疗敏感性影响的比较研究。
Oncol Res. 2024 Apr 23;32(5):817-830. doi: 10.32604/or.2024.048988. eCollection 2024.
8
The Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Outcomes in Patients With Cancer: A Systematic Review and Meta-Analysis.钠-葡萄糖协同转运蛋白2抑制剂对癌症患者心血管结局的影响：一项系统评价和荟萃分析。
Am J Cardiol. 2024 Apr 1;216:87-90. doi: 10.1016/j.amjcard.2024.01.032. Epub 2024 Feb 17.
9
SGLT2 Inhibitors as Potential Anticancer Agents.钠-葡萄糖协同转运蛋白2抑制剂作为潜在的抗癌药物
Biomedicines. 2023 Jun 30;11(7):1867. doi: 10.3390/biomedicines11071867.
10
SGLT2 promotes pancreatic cancer progression by activating the Hippo signaling pathway via the hnRNPK-YAP1 axis.钠-葡萄糖协同转运蛋白2（SGLT2）通过hnRNPK-YAP1轴激活Hippo信号通路促进胰腺癌进展。
Cancer Lett. 2021 Oct 28;519:277-288. doi: 10.1016/j.canlet.2021.07.035. Epub 2021 Jul 24.